West Pharmaceutical Services (WST) Dividends Paid - Common (2009 - 2026)

West Pharmaceutical Services has disclosed Dividends Paid - Common across 18 years of filings, most recently posting $15.8 million for Q1 2026.

• Dividends Paid - Common for Q1 2026 came in at $15.8 million, up 3.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $61.8 million (up 3.69% YoY), and the FY2025 annual result was $61.2 million, up 3.55% from the prior year.
• Dividends Paid - Common came in at $15.8 million for Q1 2026 at West Pharmaceutical Services, roughly flat from $15.8 million in the prior quarter.
• In the past five years, Dividends Paid - Common ranged from a high of $15.8 million in Q4 2025 to a low of $13.1 million in Q2 2022.
• The 5-year median for Dividends Paid - Common is $14.6 million (2024), against an average of $14.5 million.
• Across the five-year window, Dividends Paid - Common climbed 7.63% in 2023 and gained 3.27% in 2025, its largest moves.
• West Pharmaceutical Services' Dividends Paid - Common stood at $14.1 million in 2022, then advanced by 4.96% to $14.8 million in 2023, then advanced by 3.38% to $15.3 million in 2024, then gained by 3.27% to $15.8 million in 2025, then changed by 0.0% to $15.8 million in 2026.
• The last three Dividends Paid - Common figures came in at $15.8 million (Q1 2026), $15.8 million (Q4 2025), and $15.1 million (Q3 2025), per Business Quant data.